Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a24f9c507de4e6b0

Jump to content

Talk:Fractyl Health

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 1 year ago by MaryGaulke in topic Comments left during AfC process

Disclosing COI

[edit]

Hi! Getting it on the record here that I, the author of the initial draft of this page, have a COI: Fractyl is a client of my employer, Porter Novelli. I'm happy to help with any feedback to ensure this article's neutrality and value. Thanks for your time. Mary Gaulke (talk) 15:11, 25 February 2025 (UTC)Reply

Comments left during AfC process

[edit]
  • Comment: Article is promotional, and sourced almost entirely to announcements about its products, rather than about the company itself. Ref. 2 is probably fine, but the others are routine announcements and/or not about the company. Please tone down promotional content and emphasize secondary coverage of Fractyl (not its products) in reliable sources, ideally for a general audience (trade publications are fine but shouldn't form the backbone of the article). WeirdNAnnoyed (talk) 12:09, 4 March 2025 (UTC)Reply

Comment: In addition to making some edits, listing what I believe is the most significant coverage of this org (also cited in the article) in case it's helpful in reviewing:

  • Baxter, Amy (10 February 2025). "Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments". PharmaVoice. Retrieved 7 March 2025.
  • DeFeudis, Nicole (16 June 2021). "After a decade in the type 2 diabetes game, Fractyl Laboratories recharges with a fresh $100M and a new name". Endpoints News. Archived from the original on 16 June 2021. Retrieved 10 January 2025.
  • Fonseca, Camilo (18 January 2024). "Lexington-based Fractyl Health, focused on non-drug treatments for diabetes and obesity, filing for IPO". The Lexington Observer. Retrieved 9 January 2025.
  • Lawrence, Stacy (14 October 2015). "FierceMedicalDevices' 2015 Fierce 15". Fierce Biotech. Retrieved 20 May 2025.

Thank you! Mary Gaulke (talk) 15:19, 20 May 2025 (UTC)Reply